-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Clinically, there are many diseases that can cause dementia, such as Alzheimer's disease, Lewy body dementia, Parkinson's disease, vascular dementia, and frontotemporal dementia, which may cause symptoms such as hallucinations and delusions in patients
Vascular FDA researchers recently investigated the effects of pimaserin on the psychiatric symptoms of patients with dementia of various causes
Patients with psychiatric symptoms caused by diseases such as Alzheimer’s disease, Lewy body dementia, Parkinson’s disease, vascular dementia, and frontotemporal dementia participated in the study.
392 patients participated in the open treatment, 41 withdrew due to ineffectiveness, and the remaining 351 patients underwent follow-up trials, of which 217 (61.
Twelve people in the pimaserin group experienced recurrence of psychosis (13%), while 28 people (28%) in the placebo group had a recurrence risk ratio of 0.
Differences in risk of recurrence of psychosis between groups
Studies believe that pimaserin has a good therapeutic effect on dementia-related psychosis caused by a variety of diseases
Pimaserin has a good therapeutic effect on dementia-related psychosis caused by various diseases.
Original source:
Pierre N.
Trial of Pimavanserin in Dementia-Related Psychosis.
Leave a message here